Savvy Updates, 1/27/25: Insulin Costs Drop, Omnipod Dash Travel Alert, FDA At-a-Glance Nutrition Info, Modulim & Amputation Research, FTC’s Ultimatum to CVS Health, ADA & Xeris on Hypoglycemia Education, Turmeric & Diabetes, Why US Healthcare is Broken

Savvy Updates, 1/27/25: Insulin Costs Drop, Omnipod Dash Travel Alert, FDA At-a-Glance Nutrition Info, Modulim & Amputation Research, FTC’s Ultimatum to CVS Health, ADA & Xeris on Hypoglycemia Education, Turmeric & Diabetes, Why US Healthcare is Broken

In this week’s issue of The Savvy Diabetic:  Insulin Costs Drop Omnipod Dash Travel Alert FDA At-a-Glance Nutrition Info Modulim & Amputation Research FTC’s Ultimatum to CVS Health ADA & Xeris on Hypoglycemia Education Turmeric & Diabetes...
Savvy Update 2/5/24:  Lilly, Novo Trillion $ Stocks, Pancreas Can Regenerate, Indigo CGM/CMM, Non-sugar Sweeteners Alter Gut, Medicare Drug Price Negotiations Begin, Think Like a Pancreas Podcast, FREE GIVEAWAY!!!

Savvy Update 2/5/24: Lilly, Novo Trillion $ Stocks, Pancreas Can Regenerate, Indigo CGM/CMM, Non-sugar Sweeteners Alter Gut, Medicare Drug Price Negotiations Begin, Think Like a Pancreas Podcast, FREE GIVEAWAY!!!

Lilly, Novo could be first trillion-dollar health stocks: world’s largest sovereign wealth fund by Dulan Lokuwithana for SeekAlpha.com, 31 January 2024. Weight loss drugmakers Eli Lilly and Novo Nordisk could be the first healthcare stocks to achieve the $1T...
Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy by Joshua Fineman for SeekingAlpha.com, 30 August 2023.   Insulet rose 8.1% at least partly after the insulin pump maker was granted a temporary restraining order in a trade secrets case...
Savvy Updates, 8/14/23:  Medicare Covers Libre 3, Senseonics Seeks iCGM Designation, 5000 Steps are Enough, New Bill to Expand Drug Negotiations Under Medicare, Chinese microbial DPP4, Green Space & Blood Pressure, GLP-1 Agonists & Retinopathy, Satisfy Your Sweet Tooth, Take an Insulin Pump Vacation – Be Prepared

Savvy Updates, 8/14/23: Medicare Covers Libre 3, Senseonics Seeks iCGM Designation, 5000 Steps are Enough, New Bill to Expand Drug Negotiations Under Medicare, Chinese microbial DPP4, Green Space & Blood Pressure, GLP-1 Agonists & Retinopathy, Satisfy Your Sweet Tooth, Take an Insulin Pump Vacation – Be Prepared

Medicare Covers FreeStyle Libre 3 CGM by Andrew Briskin and April Hopcroft for diaTribe.org, 4 August 2023. Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare.  Following news in April that...
Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

New Systematic Review of Exocrine Pancreatic Insufficiency (EPI) In Type 1 Diabetes and Type 2 Diabetes – Focusing on Prevalence and Treatment by Dana Lewis for DIYPS.org, 13 July 2023.         I’m thrilled that the research I did evaluating the...
Skip to content